Tamsulosin Hydrochloride (MR) & Solifenacin Succinate Tablets

Tamsulosin Hydrochloride (MR) & Solifenacin Succinate Tablets are combination medications used for the management of lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) and overactive bladder. The formulation combines Tamsulosin Hydrochloride Modified Release, an alpha-1 adrenergic receptor blocker that relaxes smooth muscles in the prostate and bladder neck, with Solifenacin Succinate, an antimuscarinic agent that helps reduce involuntary bladder contractions. Genliva Wellness LLP is a trusted Tamsulosin Hydrochloride (MR) & Solifenacin Succinate Tablet Manufacturer in India offering high-quality urology formulations for domestic and international pharmaceutical markets.

This combination therapy is widely prescribed for patients experiencing both obstructive and storage urinary symptoms such as urinary urgency, increased frequency, nocturia, and incomplete bladder emptying. The modified-release technology of Tamsulosin provides sustained symptom control, while Solifenacin improves bladder storage function. As a reliable Tamsulosin Hydrochloride (MR) & Solifenacin Succinate Tablet Exporter from India, Genliva Wellness LLP supplies quality-assured pharmaceutical products to healthcare providers and distributors worldwide.

Tamsulosin Hydrochloride (MR) & Solifenacin Succinate Tablets are commonly utilized in modern urology practice to improve urinary comfort, bladder control, and overall quality of life in patients with BPH-associated urinary symptoms. Genliva Wellness LLP also offers Tamsulosin Hydrochloride (MR) & Solifenacin Succinate Tablet Contract Manufacturing in India and private-label manufacturing services for global pharmaceutical companies.